CUAMC
NKTR icon

China Universal Asset Management Company’s Nektar Therapeutics NKTR Stock Holding History

China Universal Asset Management Company’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$288K Buy
+4,000
New +$228K 0.02% 318
2023
Q4 		– Sell
-325
Closed -$2.91K – 465
2023
Q3 		$2.91K Buy
325
+160
+97% +$1.54K ﹤0.01% 417
2023
Q2 		$1.43K Sell
165
-6
-4% -$64 ﹤0.01% 442
2023
Q1 		$1.8K Buy
171
+44
+35% +$1.33K ﹤0.01% 434
2022
Q4 		$4.32K Buy
127
+10
+9% +$484 ﹤0.01% 312
2022
Q3 		$6K Buy
+117
New +$6.96K ﹤0.01% 258

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

China Universal Asset Management Company's NKTR Position: Q1 2026 in Review

China Universal Asset Management Company opened a new position in Nektar Therapeutics (NKTR) in Q1 2026: 4,000 shares worth $288K. The stake represents 0.02% of the portfolio and ranks #318 among its holdings. This is a return to the name: China Universal Asset Management Company previously reported a position in NKTR as recently as Q3 2023.

China Universal Asset Management Company first reported a position in NKTR in Q3 2022 and has held it in 6 quarters since. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • China Universal Asset Management Company held 4,000 shares of Nektar Therapeutics worth $288K as of Q1 2026.
  • Nektar Therapeutics was a new China Universal Asset Management Company position in Q1 2026.
  • Nektar Therapeutics made up 0.02% of China Universal Asset Management Company's portfolio in Q1 2026, its #318 holding.
  • China Universal Asset Management Company first reported a position in Nektar Therapeutics in Q3 2022 and has held it in 6 quarters since.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.